AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitaxa M XR 50+500 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaxa M XR 50+500 Tablet

Diabex Duo XR 50/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, and may lower the risk of cardiovascular events. Diabex Duo XR may be used alone or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing, at the same time each day, is crucial for efficacy; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise regimen is vital for diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, especially with concurrent use of insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Interactions with other medications are possible; disclose all medications to your doctor. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Sitaxa M XR 50+500 Tablet

Managing type 2 diabetes

Major Benefits of Sitaxa M XR 50+500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitaxa M XR 50+500 Tablet with a meal.

Common Side effects of Sitaxa M XR 50+500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaxa M XR 50+500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Sitaxa M XR 50+500 Tablet with a meal.

How Sitaxa M XR 50+500 Tablet works:

Sitaxa M XR 50+500 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaxa M XR 50+500 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaxa M XR 50+500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitaxa M XR 50+500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaxa M XR 50+500 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitaxa M XR 50+500 Tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Use of Sitaxa M XR 50+500 Tablet is contraindicated in individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Sitaxa M XR 50+500 Tablet :

Should you forget a dose of Sitaxa M XR 50+500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sitaxa M XR 50+500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaxa M XR 50+500 Tablet

Sitaxa M XR 50+500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaxa M XR 50+500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaxa M XR 50+500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Sitaxa M XR 50+500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M XR 50+500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sitaxa M XR 50+500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitaxa M XR 50+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaxa M XR 50+500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaxa M XR 50+500 Tablets are contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M XR 50+500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitaxa M XR 50+500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaxa M XR 50+500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M XR 50+500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaxa M XR 50+500 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitaxa M XR 50+500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M XR 50+500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitaxa M XR 50+500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaxa M XR 50+500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Sitaxa M XR 50+500 Tablet
149